Scientists test Next-Gen malaria shot on volunteers
NCT ID NCT06735209
Summary
This is an early-stage study to check if a new experimental malaria vaccine is safe and can trigger an immune response. It will involve 22 healthy adults who have never had malaria. Researchers will give participants the vaccine or a placebo, then later expose them to malaria parasites in a controlled setting to see if the vaccine offers protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Washington - Virology Research Clinic
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.